Recurrence Score May Cut Costs for High - Risk Breast Cancer Care

Testing with 21 - gene assay linked to lower relative, absolute costs among high - risk patients
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Journal, Source Type: news